Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer

计划入组 50 人 · 首次发布于 2020 年 12 月 17 日

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

计划入组 53 人 · 首次发布于 2024 年 4 月 15 日

Capecitabine plus pembrolizumab in patients with triple negative breast cancer after chemoimmunotherapy and surgery

计划入组 220 人 · 首次发布于 2023 年 8 月 3 日

Triple-Negative Breast Cancer (formulated vaccine)

GPR161 antagonists (triple-negative breast cancer/sarcoma)

Triple-negative breast cancer(Divide and Conquer)

Triple-Gene LLC

United States

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

JAPAN BREAST CANCER RESEARCH GROUP

Japan

Onchilles Pharma Receives FDA Clearance for First-in-Class ELANE Pathway Cancer Therapeutic N17350

mTNBC Pipeline Shows Promise with Novel Therapies in Clinical Trials

Sugar-Coated Nanoparticles Show Promise for Triple-Negative Breast Cancer Treatment